Immunome, Inc. (IMNM)
Nasdaq: IMNM · Pharmaceutical Preparations · Bothell, WA · filing with the SEC since 2009
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
| Report filed | Mar 3, 2026 | Mar 19, 2025 | Mar 28, 2024 | Mar 16, 2023 | Mar 28, 2022 | Mar 25, 2021 | · |
| Revenue | 6,941 | 9,041 | 14,018 | · | · | · | · |
| For lenders | |||||||
| Interest and dividend income | · | · | · | · | · | 1 | 10 |
| Net interest income | 11,719 | 12,837 | 2,724 | 5 | -10 | -38 | -96 |
| Research and development | 177,286 | 129,542 | 23,089 | 23,272 | 14,110 | 7,486 | 8,823 |
| General and administrative | 43,768 | 32,955 | 19,657 | 13,629 | 11,094 | 4,775 | 1,525 |
| Total operating expenses | 231,054 | 314,841 | 123,548 | 36,901 | 25,204 | 12,261 | 10,348 |
| Operating income | -224,113 | -305,800 | -109,530 | -36,901 | -25,204 | -12,261 | -10,348 |
| Interest expense | · | · | · | · | · | 21 | 46 |
| Other income (expense), net | · | · | · | 5 | 493 | -5,576 | · |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income including non-controlling interests | -212,394 | -292,963 | -106,806 | -36,896 | -24,711 | · | · |
| Net income | -212,394 | -292,963 | -106,806 | -36,896 | -24,711 | -17,837 | -10,444 |
| Net income to common shareholders | -212,394 | -292,963 | -106,806 | -37,518 | -24,711 | · | · |
| Earnings per share, basic | -2.43 | -5.00 | -5.38 | -3.09 | -2.14 | -5.26 | · |
| Earnings per share, diluted | -2.43 | -5.00 | -5.38 | -3.09 | -2.14 | -5.26 | · |
| Earnings per share, basic and diluted | · | · | · | · | · | -5.26 | -9.55 |
| Weighted average shares, basic | 87,350,956 | 58,639,441 | 19,843,651 | 12,126,573 | 11,538,668 | 3,389,592 | · |
| Weighted average shares, diluted | 87,350,956 | 58,639,441 | 19,843,651 | 12,126,573 | 11,538,668 | 3,389,592 | · |
| Weighted average shares, basic and diluted | · | · | · | · | · | 3,389,592 | 1,093,959 |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTaxInterest and dividend income what its loans and securities earned
us-gaap:InterestIncomeOperatingNet interest income interest earned less interest paid
us-gaap:InterestIncomeExpenseNetResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest expense what its borrowing cost
us-gaap:InterestExpenseDebtOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income including non-controlling interests the whole group's profit, minority holders' share included
us-gaap:ProfitLossNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossNet income to common shareholders what is left for common shareholders
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasicEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedEarnings per share, basic and diluted net income per share, where both counts are the same
us-gaap:EarningsPerShareBasicAndDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstandingWeighted average shares, basic and diluted the average count, where both counts are the same
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted